Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Adapalene,Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Zhaoke Ophthalmology
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 06, 2018
Lead Product(s) : Adapalene,Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Zhaoke Ophthalmology
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Adapalene,Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Study Phase : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 01, 2015
Lead Product(s) : Adapalene,Clindamycin Hydrochloride
Therapeutic Area : Dermatology
Highest Development Status : Phase I/ Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Health Canada Approves CABTREO™ for Acne Vulgaris in Patients 12 and Older
Details : CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) topical gel is a prescription medicine indicated for acne vulgaris in patients 12 years of age and older.
Product Name : Cabtreo
Product Type : Antibiotic
Upfront Cash : Inapplicable
November 09, 2024
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
November 05, 2024
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clascoterone,Adapalene
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 29, 2024
Lead Product(s) : Clascoterone,Adapalene
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
CABTREO™ Topical Gel for Acne Now Available in the U.S.
Details : CABTREO (clindamycin phosphate, adapalene, benzoyl peroxide) topical gel is a prescription medicine which is now available in US for the topical treatment of acne vulgaris in age 12 years and older.
Product Name : Cabtreo
Product Type : Antibiotic
Upfront Cash : Inapplicable
January 30, 2024
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Cabtreo (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel which is indicated for the treatment of Acne Vulgaris in patients twelve years of age and older.
Product Name : Cabtreo
Product Type : Antibiotic
Upfront Cash : Inapplicable
October 20, 2023
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : IDP-126 (clindamycin 1.2%, adapalene 0.15%, benzoyl peroxide 3.1%) gel has the potential to be the first of its kind fixed dose triple combination treatment for acne vulgaris by inhibiting bacterial protein synthesis.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
January 05, 2023
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Adapalene,Inapplicable
Therapeutic Area : Dermatology
Study Phase : Phase I
Sponsor : Bausch Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Experience With Topical Acne Treatment
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 17, 2022
Lead Product(s) : Adapalene,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : Phase I
Sponsor : Bausch Health
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Ahmedabad-Based Zydus Gets USFDA Approval to Market Generic Acne Drug
Details : A combination of Adapalene (a retinoid) and Benzoyl Peroxide (an antibiotic and skin-peeling agent), the gel is used to decrease the number and severity of acne pimples. The drug will be manufactured at the group's topical facility at Ahmedabad, Zydus Li...
Product Name : Adapalene/Benzoyl Peroxide-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 06, 2022
Lead Product(s) : Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable